WILD TYPE ATTR AMYLOIDOSIS
Clinical trials for WILD TYPE ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new WILD TYPE ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for WILD TYPE ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising early trial: patisiran may ease nerve damage in rare amyloidosis
Disease control CompletedThis early-phase study looked at how well the drug patisiran works for people with a rare disease called wild-type ATTR amyloidosis that causes nerve damage. Ten adults received the treatment, and researchers tracked changes in nerve function, symptoms like dizziness and digestio…
Matched conditions: WILD TYPE ATTR AMYLOIDOSIS
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated May 26, 2026 10:11 UTC
-
Could a lifetime of exercise protect your heart from a rare disease?
Knowledge-focused CompletedThis study looked at whether being physically active over a lifetime is linked to developing a rare heart condition called wild-type transthyretin amyloid cardiomyopathy. Researchers compared exercise histories of 180 people over age 60—some with the condition, some with heart fa…
Matched conditions: WILD TYPE ATTR AMYLOIDOSIS
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC